We are live on ! Find out more

Mid Cap Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
KLRA
126
Kailera Therapeutics
KLRA
$2.5B
$2.5B $19.30 1.69%
UFPT icon
127
UFP Technologies
UFPT
$2.49B
$2.49B $321.08 1.21%
NEOG icon
128
Neogen
NEOG
$2.49B
$2.49B $11.40 0%
CDNA icon
129
CareDx
CDNA
$2.46B
$2.46B $47.52 0.96%
PGEN icon
130
Precigen
PGEN
$2.46B
$2.46B $6.86 2%
PHVS icon
131
Pharvaris
PHVS
$2.43B
$2.43B $34.76 0.23%
MLYS icon
132
Mineralys Therapeutics
MLYS
$2.4B
$2.4B $27.19 0.69%
WGS icon
133
GeneDx Holdings
WGS
$2.39B
$2.39B $80.17 2.94%
COAG
134
Hemab Therapeutics
COAG
$2.39B
$2.39B $51.10 2.47%
CLOV icon
135
Clover Health Investments
CLOV
$2.35B
$2.35B $4.42 3.28%
ALMR
136
Alamar Biosciences
ALMR
$2.35B
$2.35B $33.87 21%
XRAY icon
137
Dentsply Sirona
XRAY
$2.34B
$2.34B $11.74 0.69%
BHC icon
138
Bausch Health
BHC
$2.33B
$2.33B $6.23 1.89%
RAPP
139
Rapport Therapeutics
RAPP
$2.31B
$2.31B $48.17 2.53%
NUVB icon
140
Nuvation Bio
NUVB
$2.29B
$2.29B $6.52 1.21%
VCEL icon
141
Vericel Corp
VCEL
$2.28B
$2.28B $44.60 1.48%
URGN icon
142
UroGen Pharma
URGN
$2.28B
$2.28B $46.80 1.06%
HRMY icon
143
Harmony Biosciences
HRMY
$2.27B
$2.27B $39.05 0.13%
PVLA
144
Palvella Therapeutics
PVLA
$2.25B
$2.25B $155.94 2.44%
ADMA icon
145
ADMA Biologics
ADMA
$2.23B
$2.23B $9.97 2.26%
ADUS icon
146
Addus HomeCare
ADUS
$2.23B
$2.23B $119.24 0.08%
ESTA icon
147
Establishment Labs
ESTA
$2.21B
$2.21B $74.25 1.08%
VERA icon
148
Vera Therapeutics
VERA
$2.2B
$2.2B $30.68 2.85%
MESO
149
Mesoblast
MESO
$2.2B
$2.2B $16.97 1.74%
HCM icon
150
HUTCHMED
HCM
$2.17B
$2.17B $12.48 0.56%
3 4 5
6
7

Mid Cap Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 164 mid cap Healthcare stocks — companies in the Healthcare sector with a market cap between $2B and $10B — worth a combined $740B.

The largest by market cap are Henry Schein (HSIC) at $9.98B, Tempus AI (TEM) at $9.96B and Krystal Biotech (KRYS) at $9.78B.

Among institutional investors, ImmunityBio (IBRX) drew the most net new fund positions in Q1 2026: 145 funds opened new positions, taking total fund holders up 109 (39%) quarter-over-quarter.

  • Combined market cap: $740B across 164 stocks.
  • Mid Cap: market cap between $2B and $10B.
  • Largest constituent: Henry Schein (HSIC), $9.98B market cap.
  • Most net new fund positions in Q1 2026: ImmunityBio (IBRX), +109 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.